Wells Fargo & Company Increases Oscar Health (NYSE:OSCR) Price Target to $27.00

Oscar Health (NYSE:OSCRGet Free Report) had its price target upped by investment analysts at Wells Fargo & Company from $24.00 to $27.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 42.11% from the stock’s current price.

A number of other research analysts have also issued reports on OSCR. The Goldman Sachs Group boosted their target price on shares of Oscar Health from $16.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday, May 9th. Baird R W raised Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th. Raymond James started coverage on Oscar Health in a research note on Friday, March 22nd. They set an “outperform” rating and a $20.00 target price on the stock. Bank of America reiterated a “neutral” rating and set a $21.00 price target (down previously from $25.00) on shares of Oscar Health in a research report on Thursday, May 30th. Finally, TheStreet raised Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $19.00.

Check Out Our Latest Stock Report on Oscar Health

Oscar Health Stock Down 0.3 %

Shares of Oscar Health stock opened at $19.00 on Wednesday. The stock has a market capitalization of $4.51 billion, a price-to-earnings ratio of -47.50 and a beta of 1.68. Oscar Health has a twelve month low of $4.72 and a twelve month high of $23.44. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29. The business’s 50 day simple moving average is $18.84 and its 200-day simple moving average is $14.57.

Oscar Health (NYSE:OSCRGet Free Report) last issued its earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The firm had revenue of $2.14 billion for the quarter, compared to analyst estimates of $1.99 billion. During the same period last year, the company earned ($0.18) earnings per share. The firm’s revenue for the quarter was up 45.8% on a year-over-year basis. Equities research analysts forecast that Oscar Health will post -0.04 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Mario Schlosser sold 5,808 shares of Oscar Health stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $113,023.68. Following the transaction, the insider now owns 65,920 shares in the company, valued at $1,282,803.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Mario Schlosser sold 5,808 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $113,023.68. Following the transaction, the insider now directly owns 65,920 shares of the company’s stock, valued at $1,282,803.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Steven Wolin sold 18,607 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $362,092.22. Following the completion of the sale, the chief operating officer now owns 65,316 shares of the company’s stock, valued at approximately $1,271,049.36. The disclosure for this sale can be found here. In the last 90 days, insiders sold 81,655 shares of company stock valued at $1,589,006. Company insiders own 25.11% of the company’s stock.

Institutional Trading of Oscar Health

Institutional investors have recently bought and sold shares of the company. Principal Financial Group Inc. raised its stake in shares of Oscar Health by 35.9% during the 3rd quarter. Principal Financial Group Inc. now owns 22,522 shares of the company’s stock worth $125,000 after purchasing an additional 5,954 shares in the last quarter. Barclays PLC lifted its stake in Oscar Health by 98.6% in the third quarter. Barclays PLC now owns 103,278 shares of the company’s stock valued at $576,000 after acquiring an additional 51,268 shares during the last quarter. Amalgamated Bank grew its position in Oscar Health by 10.6% in the third quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock worth $88,000 after acquiring an additional 1,516 shares in the last quarter. Swiss National Bank increased its stake in shares of Oscar Health by 9.9% during the 3rd quarter. Swiss National Bank now owns 281,900 shares of the company’s stock worth $1,570,000 after purchasing an additional 25,400 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Oscar Health by 19.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company’s stock valued at $6,268,000 after purchasing an additional 182,206 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Recommended Stories

Analyst Recommendations for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.